Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C180337-0.1 0.1 ml $416 
NAPSA / NAPA / Napsin A Antibody - NAPSIN1 Antibody (TMU-Ad02) - IHC of Napsin1 on human lung adenocarcinoma.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
NAPSA / NAPA / Napsin A Antibody - Western Blot - Western blot of NAPSIN1 expression in human lung.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
NAPSA / NAPA / Napsin A Antibody - NAPSIN1 Antibody (TMU-Ad02) - IHC of Napsin1 on human lung adenocarcinoma.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
NAPSA / NAPA / Napsin A Antibody - Western Blot - Western blot of NAPSIN1 expression in human lung.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
1 of 2
2 of 2

Monoclonal Mouse anti‑Human NAPSA / NAPA / Napsin A Antibody (clone TMU‑Ad02, DY488, IHC, WB) LS‑C180337

Monoclonal Mouse anti‑Human NAPSA / NAPA / Napsin A Antibody (clone TMU‑Ad02, DY488, IHC, WB) LS‑C180337

Antibody:
NAPSA / NAPA / Napsin A Mouse anti-Human Monoclonal (DY488) (TMU-Ad02) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human
Format:
DyLight 488, Unmodified
Other formats:
Price
Catalog Number
$416
LS-C180337-0.1
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
NAPSA / NAPA / Napsin A Mouse anti-Human Monoclonal (DY488) (TMU-Ad02) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human
Format:
DyLight 488, Unmodified
Other formats:

Specifications

Description
Napsin A antibody LS-C180337 is a DY488-conjugated mouse monoclonal antibody to human Napsin A (NAPSA / NAPA). Validated for IHC and WB.
Target
Human NAPSA / NAPA / Napsin A
Synonyms
NAPSA | Asp 4 | ASP4 | Aspartyl protease 4 | Kdap | NAP1 | Napsin A aspartic peptidase | Napsin-1 | KAP | TA01/TA02 | Napsin A | Napsin-A | SNAPA | NAP 1 | Pronapsin A
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1 Monoclonal
Clone
TMU-Ad02
Conjugations
DyLight 488. Also available Unconjugated or conjugated with Biotin, DY650, DY550.
Purification
Protein A purified
Modifications
Unmodified
Immunogen
Synthetic peptide corresponding to the N-Terminus of human NAPSIN1.
Applications
  • IHC
  • IHC - Paraffin (0.5 - 1 µg/ml)
  • Western blot (0.5 - 1 µg/ml)
  • Applications tested for the base form of this product only
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
50 mM sodium borate
Storage
Store at 4°C in the dark.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About NAPSA / NAPA / Napsin A
O96009 NM_004851 NP_004842.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 12/25/2024